These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8883334)

  • 1. Ultrastructural features of danazol-induced cholestasis: a case study.
    Alvaro D; Piat C; Francia C; Franchitto A; Furfaro S; Valente C; Capocaccia L; Gaudio E
    Ultrastruct Pathol; 1996; 20(5):491-5. PubMed ID: 8883334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of danazol-induced cholestasis with S-adenosylmethionine.
    Bray GP; Tredger JM; Williams R
    Postgrad Med J; 1993 Mar; 69(809):237-9. PubMed ID: 8497444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol-induced cholestasis.
    Silva MO; Reddy KR; McDonald T; Jeffers LJ; Schiff ER
    Am J Gastroenterol; 1989 Apr; 84(4):426-8. PubMed ID: 2929566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid therapy for a case of severe drug-induced cholestasis.
    Giannattasio A; D'Ambrosi M; Volpicelli M; Iorio R
    Ann Pharmacother; 2006 Jun; 40(6):1196-9. PubMed ID: 16720710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
    Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
    Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced cholestasis in the perfused rat liver and its reversal by tauroursodeoxycholate: an ultrastructural study.
    Abernathy CO; Zimmerman HJ; Ishak KG; Utili R; Gillespie J
    Proc Soc Exp Biol Med; 1992 Jan; 199(1):54-8. PubMed ID: 1728037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbilirubinemia and cholestasis.
    Berk PD; Javitt NB
    Am J Med; 1978 Feb; 64(2):311-26. PubMed ID: 415609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
    Azer SA; Canfield PJ; Stacey NH
    J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids.
    Miyai K; Richardson AL; Mayr W; Javitt NB
    Lab Invest; 1977 Mar; 36(3):249-58. PubMed ID: 839737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory investigation and clinical application of S-adenosyl-L-methionine in the treatment of cholestasis after total parenteral nutrition].
    Li N; Zhang H; Wang S; Zhu W; Ren J; Li J
    Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):407-10. PubMed ID: 12139793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Zhao YL; Wang JB; Zhou GD; Shan LM; Xiao XH
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):463-9. PubMed ID: 19389047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cholestasis induced by lithocholic acid in the rat. A freeze-fracture replica and thin section study.
    Miyal K; Mayr WW; Richardson AL
    Lab Invest; 1975 Apr; 32(4):527-35. PubMed ID: 1127872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic jaundice in two patients with primary amyloidosis: ultrastructural findings of the liver.
    Iwai M; Ishii Y; Mori T; Harada Y; Kitagawa Y; Kashiwadani M; Ou O; Okanoue T; Kashima K
    J Clin Gastroenterol; 1999 Mar; 28(2):162-6. PubMed ID: 10078828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids protect the liver against the cholestatic effect of large bilirubin loads.
    Villanger O; Bjørnbeth BA; Lyberg T; Raeder MG
    Scand J Gastroenterol; 1995 Dec; 30(12):1186-93. PubMed ID: 9053972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.
    Higuchi T; Hishida N; Isomura T; Takeshima H; Hayashi H
    Gastroenterol Jpn; 1992 Apr; 27(2):222-9. PubMed ID: 1577228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline-induced bile duct paucity and prolonged cholestasis.
    Hunt CM; Washington K
    Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral aluminum induces liver injury in a newborn piglet model.
    Alemmari A; Miller GG; Arnold CJ; Zello GA
    J Pediatr Surg; 2011 May; 46(5):883-7. PubMed ID: 21616246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.